| 摘要 |
In its many embodiments, the present invention relates to a novel class of phenylmorpholine and phenylthiomorpholine compounds useful as alpha2C adrenergic receptor agonists, pharmaceutical compositions containing the compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the alpha2C adrenergic receptor agonists using such compounds or pharmaceutical compositions. |
| 申请人 |
SCHERING CORPORATION;PHARMACOPEIA, INC. |
发明人 |
MCCORMICK, KEVIN D.;SHIH, NENG-YANG;MANGIARACINA, PIETRO;YU, YOUNONG;HUANG, CHIA-YU;LIU, RUIYAN;GUISE-ZAWACKI, LISA;BOYCE, CHRISTOPHER W.;ASLANIAN, ROBERT G.;DE LERA RUIZ, MANUEL;BIJU, PURAKKATTLE J.;LIANG, BO;LIU, RONG-QIANG |
